SGLT2 and SLGT1/2 Inhibitor for Diabetes and Non-diabetes Patients-Endocrinologist’s View
[Speaker] 최성희 / 서울의대
CV Outcome Trials of SGLT2 and SLGT1/2 Inhibitor-Cardiologist’s View
[Speaker] 조현재 / 서울의대
Renal Outcome Trials of SGLT2 and SLGT1/2 Inhibitor-Nephrologist’s View
[Speaker] 최범순 / 가톨릭의대
SGLT2 or SLGT1/2 Inhibitor for CV and Renal Outcomes of Non-diabetic Patients?
[Speaker] 오재원 / 연세의대
Discussion